[no definition available]
EC 3.1.4.35;
cGMP-binding cGMP-specific phosphodiesterase;
CGB-PDE
| Timeframe | Studies on this Protein(%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|---|---|---|---|---|
| avanafil | Canis lupus familiaris (dog) | IC50 | 0.0052 | 1 | 1 |
| t 1032 | Canis lupus familiaris (dog) | IC50 | 0.0010 | 1 | 1 |
| pf 04217903 | Canis lupus familiaris (dog) | IC50 | 8.0600 | 1 | 1 |
| chf6001 | Canis lupus familiaris (dog) | IC50 | 1.0000 | 1 | 1 |
| sildenafil | Canis lupus familiaris (dog) | IC50 | 0.0024 | 2 | 2 |
| zaprinast | Canis lupus familiaris (dog) | IC50 | 0.7600 | 1 | 1 |